The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for SonaCare Medical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
SonaCare Medical LLC (SonaCare Medical), is a medical device company that manufactures ultrasound surgical ablation systems. The company’s products comprise sonablate 450 and sonatherm. It develops technologies for urological indications providing procedures that control cancer and significantly improve quality of life. SonaCare Medical also markets image-guided acoustic ablation devices for the detection of cancer and soft tissue diseases. The company conducts clinical trials to determine the safety and efficacy of minimally invasive prostate cancer treatment using ultrasound. It operates in the US and Canada. SonaCare Medical is headquartered in Charlotte, North Carolina, the US.
The key metrics of SonaCare Medical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As SonaCare Medical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as SonaCare Medical.
For a detailed understanding of the performance of SonaCare Medical, buy the report here.